TY - JOUR T1 - Detecting COVID-19 Related Pneumonia on CT Scans using Hyperdimensional Computing JF - medRxiv DO - 10.1101/2021.05.21.21257631 SP - 2021.05.21.21257631 AU - Neftali Watkinson AU - Tony Givargis AU - Victor Joe AU - Alexandru Nicolau AU - Alexander Veidenbaum Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/25/2021.05.21.21257631.abstract N2 - Pneumonia is a common complication associated with COVID-19 infections. Unlike common versions of pneumonia spread quickly through large lung regions, COVID-19 related pneumonia starts in small localized pockets before spreading over the course of several days. This makes the infection more resilient and with a high probability of developing acute respiratory distress syndrome. Because of the peculiar spread pattern, the use of pulmonary computerized tomography (CT) scans was key in identifying COVID-19 infections. Identifying uncommon pulmonary diseases could be a strong line of defense in early detection of new respiratory infection-causing viruses. In this paper we describe a classification algorithm based on hyperdimensional computing for the detection of COVID-19 pneumonia in CT scans. We test our algorithm using three different datasets. The highest reported accuracy is 95.2% with an F1 score of 0.90, and all three models had a precision of 1 (0 false positives).Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data is publicly available by referenced papers and completely deidentifiedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe reference to the data sources is included in the paper ER -